Cargando…
Metabolic Barriers to Glioblastoma Immunotherapy
SIMPLE SUMMARY: Glioblastoma (GBM) is an aggressive brain tumor with limited prognosis despite multimodal treatment approaches. Various immunotherapies have been investigated to address the need for novel therapeutic options in GBM with limited success. Recently, alterations in the metabolism of can...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000693/ https://www.ncbi.nlm.nih.gov/pubmed/36900311 http://dx.doi.org/10.3390/cancers15051519 |